MarketCap
Facebook
X
TelegramAnnual report 2025
added 03-02-2026
Harrow Health ROE Ratio 2011-2026 | HROW
Annual ROE Ratio Harrow Health
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -9.8 | -25.1 | -34.67 | -51.05 | -159.55 | -12.51 | 0.61 | 59.09 | -458.32 | -296.75 | 1147.94 | -124.15 | -50.58 | -53.85 | 56.11 |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 1147.94 | -458.32 | -0.84 |
Quarterly ROE Ratio Harrow Health
| 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -26.59 | -36.08 | -57.27 | -40.98 | -46.8 | -45.3 | -53.36 | -55.86 | -805.74 | -1549.8 | -1646.29 | -890.59 | -941.89 | -243.31 | -138.49 | -61.37 | -29.59 | 53.49 | 63.46 | -16.58 | -57.96 | -131.13 | -138.84 | -8.98 | -19.14 | 12.09 | 30.86 | -14.16 | -231.83 | -439.34 | -392.78 | -352.35 | -412.21 | -254.4 | -383.27 | -201.88 | 83.46 | 428.66 | 770.1 | 777.98 | 747.89 | 432.46 | 131.3 | -90.47 | -104.21 | -87.88 | -70.7 | -38.13 | -50.59 | -49.3 | -47.68 | -39.32 | -34.3 | -16.81 | 5.93 | 40.13 | 5.02 | 9.67 | 25.43 |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 777.98 | -1646.29 | -114.16 |
ROE Ratio of other stocks in the Drug manufacturers industry
| Issuer | ROE Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
AcelRx Pharmaceuticals
ACRX
|
-83.89 | - | 7.5 % | $ 6.35 M |  USA |
 |
Agile Therapeutics
AGRX
|
88.64 | - | 10.11 % | $ 58.2 M | USA |
 |
Adamis Pharmaceuticals Corporation
ADMP
|
3276.74 | - | 0.86 % | $ 117 M | USA |
 |
Aerie Pharmaceuticals
AERI
|
431.6 | - | - | $ 754 M | USA |
 |
Catalent
CTLT
|
-28.94 | - | - | $ 11.5 B | USA |
 |
Eagle Pharmaceuticals
EGRX
|
15.26 | - | -39.89 % | $ 27.7 M | USA |
 |
Endo International plc
ENDP
|
37.13 | - | - | $ 28.9 M |  Irlanda |
 |
DURECT Corporation
DRRX
|
-186.86 | - | - | $ 50.1 M | USA |
 |
Alimera Sciences
ALIM
|
-43.6 | - | - | $ 142 M | USA |
 |
Athenex
ATNX
|
1589.72 | - | -23.39 % | $ 1.76 M | USA |
 |
Avadel Pharmaceuticals plc
AVDL
|
-66.13 | - | - | $ 2.06 B |  France |
 |
Evoke Pharma
EVOK
|
302.08 | - | - | $ 36.6 M | USA |
 |
Cumberland Pharmaceuticals
CPIX
|
-8.33 | $ 3.12 | 0.97 % | $ 43.9 M | USA |
 |
Cronos Group
CRON
|
-4.28 | $ 2.57 | -0.39 % | $ 1.35 B |  Canada |
 |
Calliditas Therapeutics AB (publ)
CALT
|
-50.54 | - | -0.1 % | $ 2.03 B |  Schweden |
 |
HEXO Corp.
HEXO
|
-98.17 | - | 2.45 % | $ 38.1 M | Canada |
 |
Bausch Health Companies
BHC
|
57.93 | $ 5.72 | 2.14 % | $ 2.09 B | Canada |
 |
Aurora Cannabis
ACB
|
-154.42 | $ 3.48 | 1.46 % | $ 86.3 M | Canada |
 |
Canopy Growth Corporation
CGC
|
-122.76 | $ 1.08 | 2.86 % | $ 116 M | Canada |
 |
OrganiGram Holdings
OGI
|
-45.46 | $ 1.42 | 1.43 % | $ 402 M | Canada |
 |
Jupiter Wellness
JUPW
|
-194.84 | - | - | $ 33.6 M | USA |
 |
Lannett Company
LCI
|
92.26 | - | 1.15 % | $ 7.11 M | USA |
 |
Neoleukin Therapeutics
NLTX
|
-34.11 | - | - | $ 193 M | Canada |
 |
Evolus
EOLS
|
223.5 | $ 4.33 | 1.41 % | $ 279 M | USA |
 |
Emergent BioSolutions
EBS
|
-117.13 | $ 8.24 | 3.52 % | $ 422 M | USA |
 |
Sundial Growers
SNDL
|
-88.87 | $ 1.37 | -3.52 % | $ 3.37 M | Canada |
 |
Organogenesis Holdings
ORGO
|
0.33 | $ 2.38 | - | $ 313 M | USA |
 |
Pacira BioSciences
PCRX
|
-12.79 | $ 24.06 | 1.13 % | $ 1.11 B | USA |
 |
PetIQ
PETQ
|
0.96 | - | 1.64 % | $ 400 M | USA |
 |
ProPhase Labs
PRPH
|
29.02 | - | - | $ 5.07 M | USA |
 |
Relmada Therapeutics
RLMD
|
-66.33 | $ 7.38 | 1.23 % | $ 291 M | USA |
 |
Assertio Holdings
ASRT
|
-32.33 | $ 18.02 | - | $ 115 M | USA |
 |
Radius Health
RDUS
|
27.81 | - | - | $ 1.42 B | USA |
 |
Recro Pharma
REPH
|
-22.63 | - | -4.76 % | $ 65.3 M | USA |
 |
OptiNose
OPTN
|
40.97 | - | - | $ 1.08 B | USA |
 |
SCYNEXIS
SCYX
|
-17.44 | $ 1.01 | 1.0 % | $ 50.4 M | USA |
 |
PLx Pharma
PLXP
|
-129.32 | - | -27.8 % | $ 2.56 M | USA |
 |
Solid Biosciences
SLDB
|
-96.84 | $ 8.39 | 4.61 % | $ 734 M | USA |
 |
Tilray
TLRY
|
-43.81 | $ 6.72 | 2.28 % | $ 4.15 B | Canada |
 |
Sonoma Pharmaceuticals
SNOA
|
-78.37 | $ 2.35 | 3.07 % | $ 2.92 M | USA |
 |
Veru
VERU
|
-116.97 | $ 2.38 | - | $ 321 M | USA |
 |
Viatris
VTRS
|
0.27 | $ 13.83 | 2.67 % | $ 16.6 B | USA |
 |
cbdMD
YCBD
|
-7.78 | $ 0.75 | 9.54 % | $ 3.23 M | USA |
 |
Zomedica Corp.
ZOM
|
-70.94 | - | -0.21 % | $ 98 M | USA |
 |
Zynerba Pharmaceuticals
ZYNE
|
-75.79 | - | - | $ 55.5 M | USA |
 |
Rockwell Medical
RMTI
|
-14.37 | $ 0.94 | 3.31 % | $ 33.8 M | USA |
 |
Tricida
TCDA
|
-80993.58 | - | - | $ 3.25 M | USA |
 |
China Pharma Holdings
CPHI
|
-14.02 | $ 0.65 | 0.6 % | $ 2.79 M |  China |
 |
TherapeuticsMD
TXMD
|
-2.12 | $ 2.05 | -0.97 % | $ 23.7 M | USA |